About Amphasys

Amphasys is a Swiss biotech company headquartered in Lucerne, in the heart of Switzerland. The company offers innovative technology for the analysis of singular cells. Applications range from plant breeding and seed production to cellular agriculture, precision fermentation and regenerative medicine. With its technology and consulting services, Amphasys helps various industries meet the challenge of feeding a growing population under limited resources and changing climate conditions.

Note: This article has been translated using a computer system without human intervention. LUMITOS offers these automatic translations to present a wider range of company presentation. Since this article has been translated with automatic translation, it is possible that it contains errors in vocabulary, syntax or grammar. The original article in German can be found here.

Facts about Amphasys
  • Founding: 2012
  • Focus : Manufacturer
  • Employees: 11-50
  • Industry : Laboratory analysis / Laboratory measurement technology

Product portfolio of Amphasys

Product portfolio

Here you will find Amphasys AG

See the theme worlds for related content

Topic World Cell Analysis

Cell analyse advanced method allows us to explore and understand cells in their many facets. From single cell analysis to flow cytometry and imaging technology, cell analysis provides us with valuable insights into the structure, function and interaction of cells. Whether in medicine, biological research or pharmacology, cell analysis is revolutionizing our understanding of disease, development and treatment options.

5+ products
5 whitepaper
5+ brochures
View topic world

Topic World Cell Analysis

Cell analyse advanced method allows us to explore and understand cells in their many facets. From single cell analysis to flow cytometry and imaging technology, cell analysis provides us with valuable insights into the structure, function and interaction of cells. Whether in medicine, biological research or pharmacology, cell analysis is revolutionizing our understanding of disease, development and treatment options.

5+ products
5 whitepaper
5+ brochures